Form 8-K - Current report:
SEC Accession No. 0001854270-25-000073
Filing Date
2025-06-30
Accepted
2025-06-30 16:02:07
Documents
12
Period of Report
2025-06-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K snti-20250625.htm   iXBRL 8-K 34815
  Complete submission text file 0001854270-25-000073.txt   154307

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20250625.xsd EX-101.SCH 1785
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20250625_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20250625_pre.xml EX-101.PRE 13045
14 EXTRACTED XBRL INSTANCE DOCUMENT snti-20250625_htm.xml XML 2835
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 239-2030
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 251091904
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)